%0 Online Multimedia %A Tameris, Michele %A Mearns, Helen %A Penn-Nicholson, Adam %A Gregg, Yolande %A Bilek, Nicole %A Mabwe, Simbarashe %A Geldenhuys, Hennie %A Shenje, Justine %A Luabeya, Angelique %A Murillo, Ingrid %A Doce, Juana %A Aguilo, Nacho %A Marinova, Dessislava %A Rodriguez, Esteban %A Pentes, Eugenia %A Gonzalo-Asensio, Jesús %A Fritzell, Bernard %A Thole, Jelle %A Martin, Carlos %A Scriba, Thomas %A Hatherill, Mark %A Team, MTBVAC Clinical Trial %D 2019 %T Statistical Analysis Plan %U https://zivahub.uct.ac.za/articles/presentation/Statistical_Analysis_Plan/7970177 %R 10.25375/uct.7970177.v1 %2 https://zivahub.uct.ac.za/ndownloader/files/14840024 %K MTBVAC %K infants %K tuberculosis %K clinical trial %K Immunology %X Statistical analysis plan for the MTBVAC 201 clinical trial. A phase Ib, randomised, double-blind, dose-escalation clinical trial of the safety, reactogenicity and immunogenicity of MTBVAC compared to BCG Vaccine SSI, in newborns living in a tuberculosis endemic region with a safety arm in adults. %I University of Cape Town